X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/q-biomed-announces-addition-of-multi-million-dollar-asset-value-with-equity-stake-in-maniin-research-inc-301677145.html
https://www.prnewswire.com/news-releases/q-biomed-announces-issuance-of-patent-for-groundbreaking-gdf15-biomarker-301634040.html
https://www.prnewswire.com/news-releases/q-biomed-inc-provides-update-to-shareholders-301596148.html
https://www.prnewswire.com/news-releases/q-biomed-announces-publication-of-pre-clinical-research-showing-superior-safety-and-efficacy-against-current-first-line-therapy-of-its-drug-candidate-uttroside-b-for-liver-cancer-301593225.html
https://www.prnewswire.com/news-releases/q-biomed-outlines-strategy-and-value-proposition-in-multi-billion-dollar-markets-301541664.html
https://www.prnewswire.com/news-releases/q-biomed-announces-publication-of-research-showing-augmented-efficacy-of-its-drug-candidate-uttroside-b-against-liver-cancer-301503998.html
https://www.prnewswire.com/news-releases/q-biomed-announces-initial-500k-order-of-strontium89-to-chinese-market-301496659.html
https://www.prnewswire.com/news-releases/q-biomed-outlines-strategic-direction-for-2022-301481726.html
https://www.prnewswire.com/news-releases/q-biomed-inc-updates-on-covid-19-therapeutic-development-and-clinical-trials---man-19-therapeutic-program-heading-to-clinical-trial-in-early-2022-301382299.html
Market Place
Share 
